StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
ELVElevance Health, Inc.
stockpulse.co.kr
NYSE
$440.00▲ 0.03%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $95.42BShares out 2.200M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

8
  • 1d agoAfter-hours26.10.24 05:30
    4Ownership#●●●

    Elevance Health, Inc.

    Elevance Health executive Mark Kaye reported a change in beneficial ownership of securities on October 22, 2026. This filing is a standard Form 4 disclosure regarding insider stock holdings.…more

    $440.00+0.03%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 2d agoAfter-hours26.10.23 05:03
    144Ownership

    Elevance Health, Inc.

    Elevance Health, Inc. insider Kaye Mark has filed an SEC Form 144 to report a proposed sale of securities. This filing represents a standard disclosure regarding the disposition of shares by an insider.…more

    $440.00+0.03%vs prev close
    View filingShare
  • 3d agoRegular26.10.22 03:14
    10-QEarnings

    Elevance Health, Inc.

    Elevance Health has filed its 10-Q quarterly report for the period ending September 30, 2026. The filing includes certifications from the CEO and CFO regarding the accuracy of financial statements and the effectiveness of internal controls over financial reporting.…more

    $440.00+0.03%vs prev close
    View filingShare

7 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 4d agoPre-market26.10.21 22:14
    #●●●#●●●

    Elevance Health Highlights Commercial Growth Offsetting Medicaid Attrition…more

    Elevance Health stated that growth in its commercial fee-based membership is offsetting anticipated attrition in its Medicaid business. The company also reaffirmed its commitment to maintaining a 2% to 4% margin target for its Medicaid segment.…more

    $440.00+0.03%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 4d agoPre-market26.10.21 21:41

    ●●●●●●●● ●●●●● ●●●●●●

    Elevance Health reported that its third-quarter Medicaid performance exceeded expectations, driven primarily by recent rate adjustments. The company expects Medicaid margins to improve by 2027 as reimbursement rates better align with cost trends.…more

    $440.00+0.03%vs prev close
    ShareBenzinga
  • 4d agoPre-market26.10.21 19:01

    ●●●●●●●● ●●●●● ●●●●●●

    Elevance Health reported third-quarter adjusted EPS and revenue that both surpassed analyst expectations. The company demonstrated growth with a 15.92% increase in EPS and a 0.70% rise in revenue compared to the same period last year.…more

    $440.00+0.03%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →